The Biden administration is weighing every option to strike down a “reckless” ruling by a federal judge in Texas that suspended a US approval of a key drug used in medication abortions, Xavier Becerra, the Secretary of Health and Human Services, said on Sunday.

Competing orders issued Friday by a pair of federal judges on the FDA’s approval of mifepristone potentially sets up another politically seismic abortion ruling a year after the U.S. Supreme Court overturned Roe v. Wade.

President Joe Biden vowed to fight a ruling from a conservative judge in Texas that could block a widely used abortion drug, thrusting the issue of reproductive rights back into the spotlight ahead of the 2024 election.

The most common abortion method in the US is at risk of disappearing from the market, at least temporarily, after a Texas judge granted an injunction against the US Food and Drug Administration’s decades-old approval for mifepristone, also known as the abortion pill.

The FDA’s safety limits on the abortion pill will remain in place at least temporarily in 17 states and Washington, D.C., while a federal judge in Washington state considers a final decision on a Democratic state-led challenge to the restrictions.

British American Tobacco has made another investment in cannabis as part of its push to diversify away from cigarettes, this time partnering with CBD firm Charlotte’s Web to develop a drug for an undisclosed neurological condition.